Health biotech firms with developing country partners better postitioned to innovate, prosper
McLaughlin-Rotman Centre for Global Health 9 Sep 2009 Lower manufacturing, clinical trial, R&D costs of developing country partners equal major […]
McLaughlin-Rotman Centre for Global Health 9 Sep 2009 Lower manufacturing, clinical trial, R&D costs of developing country partners equal major […]
Global Alliance for Chronic Diseases London / Washington / Toronto 15-Jun-2009 Six of the world’s foremost health agencies, collectively managing
McLaughlin-Rotman Centre for Global Health University of Toronto / University Health Network 7-Dec-2008 Canadian researchers have identified protein biomarkers that
McLaughlin-Rotman Centre for Global Health University of Toronto / University Health Network 20-Apr-2008 British entrepreneur, 25, created world’s top soccer
McLaughlin Rotman Centre for Global Health University of Toronto / University Health Network 7-Jan-2008 Government funds innovation but venture capital
McLaughlin-Rotman Centre for Global Health Toronto 21-Nov-2007 20 ‘Grand Challenges’ in chronic non-communicable diseases, 1st agreed roadmap to reduce rising
McLaughlin-Rotman Centre for Global Health, Toronto 10 Sep 07 The first comprehensive examination of the ethical, social and cultural (ESC)
McLaughlin-Rotman Centre for Global Health / Program on Life Sciences, Ethics and Policy 9-Apr-2007 India’s health biotech firms are emerging
University of Toronto Joint Centre for Bioethics 22-Jan-2007 Public health trumps individual human rights, medical ethics experts say Medical ethics
11-Sep-2006 University of Toronto Joint Center for Bioethics Experts rank top 10 ways of improving health in poor countries from